Rhythm Pharmaceuticals Inc (OQ:RYTM)

Business Focus: Bio Therapeutic Drugs

Recent Price for RYTM
USD 28.040 N/A (N/A)
NASDAQ Delayed 15 minutes
Dec 14 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.000 N/A N/A 765.05
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.000 0.0% 124,304  

Latest 10 SEC filings (by transaction date) for RYTM within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Oct 11/17 Oct 10/17 Mpm Bioventures V, L.P. Indirect Ownership Series A-1 Junior Preferred Stock C - Conversion -15,887,703  
Oct 11/17 Oct 10/17 Mpm Bioventures V, L.P. Indirect Ownership Series A Preferred Stock C - Conversion -7,651,831  
Oct 11/17 Oct 10/17 Mpm Bioventures V, L.P. Indirect Ownership Common Stock P - Open market or private purchase 100,000 $17.00
Oct 11/17 Oct 10/17 Mpm Bioventures V, L.P. Indirect Ownership Common Stock C - Conversion 2,567,014  
Oct 11/17 Oct 10/17 Foley Todd Indirect Ownership Series A-1 Junior Preferred Stock C - Conversion -15,887,703  
Oct 11/17 Oct 10/17 Foley Todd Indirect Ownership Series A Preferred Stock C - Conversion -7,651,831  
Oct 11/17 Oct 10/17 Foley Todd Indirect Ownership Common Stock P - Open market or private purchase 100,000 $17.00
Oct 11/17 Oct 10/17 Foley Todd Indirect Ownership Common Stock C - Conversion 2,567,014  
Oct 10/17 Oct 10/17 Viswanathan Ravi Indirect Ownership Series A-1 Junior Preferred Stock C - Conversion -2,927,708  
Oct 10/17 Oct 10/17 Viswanathan Ravi Indirect Ownership Series A Preferred Stoc C - Conversion -1,402,870  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for RYTM within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Oct 12/17 Oct 10/17 Exter Neil Indirect Ownership Series A-1 Junior Preferred Stock C - Conversion    
Oct 12/17 Oct 10/17 Exter Neil Indirect Ownership Series A Convertible Preferred Stock C - Conversion    
Oct 12/17 Oct 10/17 Exter Neil Indirect Ownership Common Stock C - Conversion    
Oct 11/17 Oct 10/17 Mpm Bioventures V, L.P. Indirect Ownership Series A-1 Junior Preferred Stock C - Conversion -15,887,703  
Oct 11/17 Oct 10/17 Mpm Bioventures V, L.P. Indirect Ownership Series A Preferred Stock C - Conversion -7,651,831  
Oct 11/17 Oct 10/17 Mpm Bioventures V, L.P. Indirect Ownership Common Stock P - Open market or private purchase 100,000 $17.00
Oct 11/17 Oct 10/17 Mpm Bioventures V, L.P. Indirect Ownership Common Stock C - Conversion 2,567,014  
Oct 11/17 Oct 10/17 Foley Todd Indirect Ownership Series A-1 Junior Preferred Stock C - Conversion -15,887,703  
Oct 11/17 Oct 10/17 Foley Todd Indirect Ownership Series A Preferred Stock C - Conversion -7,651,831  
Oct 11/17 Aug 18/17 Foley Todd Indirect Ownership Series A Preferred Stock A - Grant, award or other under Rule 16b-3(d) 3,015,915 $1.00
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $RYTM

  • No tweets found

StockTwits